Verapamil Hydrochloride

DRUG6 trials

Conditions

Abnormal Glucose ToleranceAtrial Fibrillation (AF)Atrial Fibrillation With Rapid Ventricular ResponseCardiovascular System DiseaseCystic Fibrosis (CF)Cystic Fibrosis Related DiabetesDrug-Related Side Effects and Adverse ReactionsKeloid

Phase 1

Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

CompletedNCT03013933

City of Hope Medical CenterRecurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma

Start: 2017-05-03End: 2022-05-24Updated: 2024-02-22

A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems

TerminatedNCT03098680

Cambridge University Hospitals NHS Foundation TrustCardiovascular System Disease, Drug-Related Side Effects and Adverse Reactions

Start: 2017-04-24End: 2020-02-29Updated: 2021-03-22

Phase 2

Verapamil Effect in Cystic Fibrosis-related Dysglycemia

Not yet recruitingNCT07688070

Rhode Island HospitalAbnormal Glucose Tolerance, Cystic Fibrosis (CF), Cystic Fibrosis Related Diabetes

Start: 2026-08-01End: 2028-08-31Target: 30Updated: 2026-07-09

VIP-1 : Preclinical type 1 diabetes: the VIP-1 Study

Not yet recruitingCTIS2025-524318-27-00

Assistance Publique Hopitaux De ParisPeople with stage 1 or stage 2 T1D between the ages of 7 and 45

Target: 50Updated: 2026-08-05

Phase 4

Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)

Not yet recruitingNCT07706075

Muhammad Ali JavedAtrial Fibrillation (AF), Atrial Fibrillation With Rapid Ventricular Response

Start: 2027-01-01End: 2027-08-01Target: 120Updated: 2026-08-03

Unknown Phase

Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids

CompletedNCT07420166

Muhammad Aamir LatifKeloid